Funded Projects › FP7
EUPATI · European Patients' Academy on Therapeutic Innovation
The proposed project ""European Patients' Academy on Therapeutic Innovation"" (EUPATI) contributes to IMI’s goal of raising patients’ awareness and participation in pharmaceutical R&D. This patient-led academy will provide scientifically reliable, objective, comprehensive information to patients on pharmaceutical R&D. It will increase the capacity of well-informed patients to be effective advocates and advisors, e.g. in pharmaceutical development, with regulatory authorities and in ethics committees. The Consortium, led by the European Patients' Forum, comprises a unique combination of pan-European patient organisations, academic and not-for profit organisations and 16 EFPIA member companies. It features excellence across disease areas in state-of-the art, high quality, objective education to patients about therapeutic innovation. Supported by an innovative e-platform, EUPATI's network of patients, experts, companies and communicators develops recognised blended learning courses for patients to become 'Patient Experts' in treatment development. It provides educational materials for patient organisations as well as a Wiki-type platform available to all patients in 6 areas of interest. It drives the newest thinking in content and delivery, and harnesses previously ad-hoc activities in a coherent, strategic, quality-oriented and sustainable way. It informs the lay and hard to reach patient community, raising public awareness of the development of new treatments. EUPATI makes a substantial and measurable difference to patients, laying the base for meaningful involvement and empowerment of patients in pharmaceutical innovation, safety of medicines and access to treatments. EUPATI creates synergies across its public and private partners to galvanize the most effective, transparent and credible partnership possible, nurturing the best that industry and patient organisations can offer in this field, whilst respecting core principles of quality and independence of information.""
Consortium · 33 organisations
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV
DE
PFIZER LIMITED
UK
International Society for Pharmacoeconomics and Outcomes Research Inc
US
THE UNIVERSITY OF MANCHESTER
UK · €609,438
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
UK
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE
BE · €893,637
UCB BIOPHARMA
BE
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
BE · €56,245
EURORDIS - RARE DISEASES EUROPE
FR · €489,621
NOVARTIS PHARMA AG
CH
MERCK SHARP & DOHME CORP
US
ASTRAZENECA AB
SE
Hibernia College
IE · €384,918
KOBENHAVNS UNIVERSITET
DK · €162,028
AMGEN
BE
DIA Europe GmbH
CH · €738,610
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
DE
FORUM EUROPEEN DES PATIENTS - EUROPEAN PATIENTS' FORUM
BE · €1,232,402
Bayer Pharma AG
DE
BOEHRINGER INGELHEIM INTERNATIONALGMBH
DE
European Genetic Alliance Network
BE · €301,155
CHIESI FARMACEUTICI SPA
IT
IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE
IE · €93,276
ESTEVE PHARMACEUTICALS, SA
ES
NOVO NORDISK A/S
DK
SARD
FR
ELI LILLY AND COMPANY LTD
UK
The Employers' Union of Innovative Pharmaceutical Companies INFARMA (Związek Pracodawców Innowacyjnych Firm Farmaceutycznych)
PL
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA
ES
EUROPEAN AIDS TREATMENT GROUP EV
DE · €288,670
BRISTOL-MYERS SQUIBB COMPANY CORP
US
JANSSEN PHARMACEUTICA NV
BE
F. HOFFMANN-LA ROCHE AG
CH
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.